INNOVATION PHARMACEUTICALS INC. Initial Franchise Fees
INNOVATION PHARMACEUTICALS INC. reported Initial Franchise Fees of $1.21 million for the 12-month period ending 2020-06-30, per its 10-K filed 2020-09-14.
Discontinued › Notes
us-gaap:InitialFranchiseFees · last filed 2020-09-14
- INNOVATION PHARMACEUTICALS INC. initial franchise fees for the quarter ending 2020-06-30 was $0.00.
- INNOVATION PHARMACEUTICALS INC. initial franchise fees for the quarter ending 2019-06-30 was $0.00.
- INNOVATION PHARMACEUTICALS INC. initial franchise fees for fiscal 2020 was $1.21M, a 48.35% increase from fiscal 2019.
- INNOVATION PHARMACEUTICALS INC. initial franchise fees for fiscal 2019 was $817.00K.
| Period end | Initial Franchise Fees 3 month | Initial Franchise Fees 9 month | Initial Franchise Fees 12 month |
|---|---|---|---|
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-14 | $1.21M 10-K · filed 2020-09-14 | |
| 2020-03-31 | $1.21M 10-Q · filed 2020-05-14 | ||
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-14 | $817.00K 10-K · filed 2020-09-14 | |
| 2019-03-31 | $817.00K 10-Q · filed 2020-05-14 |